Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TRILACICLIB vs TRIMETAZIDINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TRILACICLIB vs TRIMETAZIDINE: Safety Overview

Metric TRILACICLIB TRIMETAZIDINE
Total FAERS Reports 226 431
Deaths Reported 29 33
Death Rate 12.8% 7.7%
Hospitalizations 96 264
Average Patient Age 62.2 yrs 68.4 yrs
% Female Patients 43.9% 32.3%
FDA Approval Date Feb 12, 2021 N/A
Manufacturer Pharmacosmos Therapeutics Inc. N/A
Route INTRAVENOUS N/A
Marketing Status Prescription N/A